SCHEMBL1726323

SCHEMBL1726323

CC(C)(C)OC(=O)N1CCC(c2nc(C3CC3)c(Cl)cc2N)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
MAPT P10636 3/20 0.48
THRB P10828 1/20 0.48
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
USP2 O75604 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CNR1 P21554 2/20 0.44
HTT P42858 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
STS P08842 2/20 0.43
GPR119 Q8TDV5 2/20 0.43
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2680241 0.91 KDM4E (0.48) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL13671319 0.90 KDM4E (0.50) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL1726691 0.89 KDM4E (0.46) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL1421111 0.87 KDM4E (0.47) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL1462885 0.84 MAPT (0.46) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL30625181 0.83 MEN1 (0.47) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL26602491 0.83 MEN1 (0.47) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL1463180 0.82 KDM4E (0.45) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL1462909 0.81 KDM4E (0.48) KDM4EMAPTTHRBMEN1KMT2A
SCHEMBL2681920 0.81 MEN1 (0.48) KDM4EMAPTTHRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2018-07-31 US disclosed
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2017-12-07 US disclosed
US-9808006-B2 Insecticidal phenyl-or pyridyl-piperdine compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-11-07 US disclosed
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2013-11-28 US disclosed
US-8518971-B2 Insecticidal phenyl- or pyridyl-piperdine compounds SYNGENTA CROP PROTECTION, INC. (US) 2013-08-27 US disclosed
WO-2012037282-A3 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS NOVOMER, INC. (US) 2012-05-10 WO disclosed
EP-2324010-B1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERIDINE COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2011-11-30 EP disclosed
US-20110136866-A1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERDINE COMPOUNDS SYNGENTA CROP PROTECTION LLC (US) 2011-06-09 US disclosed
EP-2324010-A1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERIDINE COMPOUNDS Syngenta Participations AG (CH) 2011-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10034476-B2 Insecticidal phenyl-or pyridyl-piperdine compounds ACHE, CHRM1, CHRM2 KDM4E 1032/4885MAPT 3218/4885THRB 3436/4885
US-20130317062-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 KDM4E 1032/4885MAPT 3218/4885THRB 3436/4885
US-20110136866-A1 INSECTICIDAL PHENYL- OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 KDM4E 1079/4885MAPT 3185/4885THRB 3656/4885
US-20170347650-A1 INSECTICIDAL PHENYL-OR PYRIDYL-PIPERDINE COMPOUNDS ACHE, CHRM1, CHRM2 KDM4E 1032/4885MAPT 3218/4885THRB 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.